Spondylodiscitis: Update on diagnosis and management

563Citations
Citations of this article
587Readers
Mendeley users who have this article in their library.

Abstract

Spondylodiscitis, a term encompassing vertebral osteomyelitis, spondylitis and discitis, is the main manifestation of haematogenous osteomyelitis in patients aged over 50 years. Staphylococcus aureus is the predominant pathogen, accounting for about half of non-tuberculous cases. Diagnosis is difficult and often delayed or missed due to the rarity of the disease and the high frequency of low back pain in the general population. In this review of the published literature, we found no randomized trials on treatment and studies were too heterogeneous to allow comparison. Improvements in surgical and radiological techniques and the discovery of antimicrobial therapy have transformed the outlook for patients with this condition, but morbidity remains significant. Randomized trials are needed to assess optimal treatment duration, route of administration, and the role of combination therapy and newer agents. © The Author 2010. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

Cite

CITATION STYLE

APA

Gouliouris, T., Aliyu, S. H., & Brown, N. M. (2010). Spondylodiscitis: Update on diagnosis and management. Journal of Antimicrobial Chemotherapy, 65(SUPPL. 3). https://doi.org/10.1093/jac/dkq303

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free